Haleon PLC closed 3.36% below its 52-week high of £4.01, which the company reached on September 18th.
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...
Haleon PLC HLN shares dropped 1.63% to £3.67 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.33% to 8,548.29. Supported ...
Pfizer PFE-2.06%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.11%decrease; red down pointing triangle for 2.50 billion ...
Jan 15 (Reuters) - Pfizer (PFE.N), opens new tab will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (HLN.L), opens new tab, lowering its stake in the British consumer healthcare ...
The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless ...
Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of Haleon’s issued share capital. “There will be no sale ...
(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner ...
Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...
(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results